Dan Li
This is a likely match — the affiliation was inferred from OpenAlex, ORCID, and web sources but has not been fully confirmed. Treat with appropriate caution.
Role not yet determined Is this you? Add your title
Also affiliated: Hubei University of Medicine (2022); United States Food and Drug Administration (2021–2025); Chinese Center For Disease Control and Prevention (2022–2025); Jilin University (2022); Chinese Academy of Sciences (2022); First Affiliated Hospital of Liaoning Medical University (2022); Fifth Affiliated Hospital of Sun Yat-sen University (2022); First Affiliated Hospital of Xi'an Jiaotong University (2022); National Center for AIDS/STD Control and Prevention,China CDC (2025); National Institute for Communicable Disease Control and Prevention (2022); Beijing Academy of Agriculture and Forestry Sciences (2022); The Sixth People's Hospital of Shenyang (2022); Hubei Cancer Hospital (2024); Huazhong University of Science and Technology (2022–2024); Hainan Medical University (2022); Jinzhou Medical University (2022)
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
Dan Li's research focuses on the application of high-throughput sequencing technologies for precision oncology and the assessment of therapeutic interventions. His work investigates the analytical validity of circulating tumor DNA sequencing assays and explores methods to augment precision medicine through targeted RNA sequencing for expressed mutations. Li has also studied gene regulation perturbations in autism spectrum disorder during neural system development and has contributed to the development of flow cytometry panels for immunoprofiling and functional assessment of human peripheral blood mononuclear cells.
Metrics
- h-index: 4
- Publications: 11
- Citations: 320
Selected Publications
-
Augmenting precision medicine via targeted RNA-Seq detection of expressed mutations (2025)
-
Assessments of tumor mutational burden estimation by targeted panel sequencing: A comprehensive simulation analysis (2023)
-
Single-cell RNA-sequencing and subcellular spatial transcriptomics facilitate the translation of liver microphysiological systems for regulatory application (2023)
-
Transcriptomic Response of Human Nosocomial Pathogen Pseudomonas aeruginosa Biofilms Following Continuous Exposure to Antibiotic-Impregnated Catheters (2022)
-
Gene Regulation Analysis Reveals Perturbations of Autism Spectrum Disorder during Neural System Development (2021)
-
Evaluating the analytical validity of circulating tumor DNA sequencing assays for precision oncology (2021)
Collaboration Network
Top Collaborators
- Gene Regulation Analysis Reveals Perturbations of Autism Spectrum Disorder during Neural System Development
- Single-cell RNA-sequencing and subcellular spatial transcriptomics facilitate the translation of liver microphysiological systems for regulatory application
- Assessments of tumor mutational burden estimation by targeted panel sequencing: A comprehensive simulation analysis
- Transcriptomic Response of Human Nosocomial Pathogen Pseudomonas aeruginosa Biofilms Following Continuous Exposure to Antibiotic-Impregnated Catheters
- Evaluating the analytical validity of circulating tumor DNA sequencing assays for precision oncology
- Augmenting precision medicine via targeted RNA-Seq detection of expressed mutations
- Single-cell RNA-sequencing and subcellular spatial transcriptomics facilitate the translation of liver microphysiological systems for regulatory application
- Evaluating the analytical validity of circulating tumor DNA sequencing assays for precision oncology
- Augmenting precision medicine via targeted RNA-Seq detection of expressed mutations
- Evaluating the analytical validity of circulating tumor DNA sequencing assays for precision oncology
- Augmenting precision medicine via targeted RNA-Seq detection of expressed mutations
- Evaluating the analytical validity of circulating tumor DNA sequencing assays for precision oncology
- Augmenting precision medicine via targeted RNA-Seq detection of expressed mutations
- Evaluating the analytical validity of circulating tumor DNA sequencing assays for precision oncology
- Augmenting precision medicine via targeted RNA-Seq detection of expressed mutations
- Evaluating the analytical validity of circulating tumor DNA sequencing assays for precision oncology
- Augmenting precision medicine via targeted RNA-Seq detection of expressed mutations
- Evaluating the analytical validity of circulating tumor DNA sequencing assays for precision oncology
- Augmenting precision medicine via targeted RNA-Seq detection of expressed mutations
- Augmenting precision medicine via targeted RNA-Seq detection of expressed mutations
- Assessments of tumor mutational burden estimation by targeted panel sequencing: A comprehensive simulation analysis
- Evaluating the analytical validity of circulating tumor DNA sequencing assays for precision oncology
- Evaluating the analytical validity of circulating tumor DNA sequencing assays for precision oncology
- Evaluating the analytical validity of circulating tumor DNA sequencing assays for precision oncology
- Evaluating the analytical validity of circulating tumor DNA sequencing assays for precision oncology
- Evaluating the analytical validity of circulating tumor DNA sequencing assays for precision oncology
- Evaluating the analytical validity of circulating tumor DNA sequencing assays for precision oncology
Similar Researchers
Based on overlapping research topics